Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2016

RXi Pharmaceuticals Corp. (RXII) Starts Presentation at Biotech Showcase Conference

Posted on January 11, 2016 by MissionIR

RXi Pharmaceuticals Corp. (NASDAQ: RXII) is a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, addressing high-unmet medical needs. The company’s discovery and clinical development programs are based on siRNA technology … Continue reading →

Posted in Biotech Showcase Conference | Leave a comment

Cyclacel Pharmaceuticals, Inc. (CYCC) Starts Presentation at Biotech Showcase Conference

Posted on January 11, 2016 by MissionIR

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. Professor Sir David Lane, a recognized leader in the field … Continue reading →

Posted in Biotech Showcase Conference | Leave a comment

Actinium Pharmaceuticals, Inc. (ATNM) Starts Presentation at Biotech Showcase Conference

Posted on January 11, 2016 by MissionIR

Actinium Pharmaceuticals, Inc. (NYSE: ANTM) is a biopharmaceutical company focused on the development of cancer drugs. The company’s product candidates are based on its patented technology, which combines the cancer targeting precision of monoclonal antibodies with the power of alpha … Continue reading →

Posted in Biotech Showcase Conference | Leave a comment

RepliCel Life Sciences, Inc. (REPCF) Starts Presentation at Biotech Showcase Conference

Posted on January 11, 2016 by MissionIR

RepliCel Life Sciences Inc. (OTC: REPCF) is a regenerative medicine company focused on developing autologous cell therapies that address conditions caused by a deficit of healthy cells required for normal healing and function. The company’s product pipeline is comprised of … Continue reading →

Posted in Biotech Showcase Conference | Leave a comment

SciClone Pharmaceuticals (SCLN) Starts Presentation at Biotech Showcase Conference

Posted on January 11, 2016 by MissionIR

SciClone Pharmaceuticals (NASDAQ: SCLN) is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. The company’s proprietary lead product, ZADAXIN® (thymalfasin), is approved in over … Continue reading →

Posted in Biotech Showcase Conference | Leave a comment

Sorrento Therapeutics, Inc. (SRNE) Starts Presentation at Biotech Showcase Conference

Posted on January 11, 2016 by MissionIR

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is a clinical-stage biopharmaceutical company developing new treatments for cancer, as well as associated pain, inflammation and immune diseases. The company recently licensed multiple late-stage biosimilar and biobetter antibodies for oncology and inflammation diseases in … Continue reading →

Posted in Biotech Showcase Conference | Leave a comment

Cytosorbents Corp. (CTSO) Starts Presentation at Biotech Showcase Conference

Posted on January 11, 2016 by MissionIR

Cytosorbents Corp. (NASDAQ: CTSO) is a critical care-focused immunotherapy company using blood purification to control severe inflammation with the goal of preventing or treating multiple organ failure in life-threatening illnesses. CytoSorb®, the company’s flagship product, is approved in the EU … Continue reading →

Posted in Biotech Showcase Conference | Leave a comment

International Stem Cell Corporation (ISCO) may be Running a Loss, but it’s also Making a Profit

Posted on January 11, 2016 by MissionIR

International Stem Cell Corporation (OTCQB: ISCO) has its fingers in many pies. It develops and markets products in three different lines, and two of those businesses turn a profit. Its biomedical division is the most profitable. For the nine months … Continue reading →

Posted in International Stem Cell Corp. ISCO | Leave a comment

Hoverboard Fires Ignite Debate about Imported Batteries, Oakridge Global Energy Solutions, Inc. (OGES) ‘Made in the USA’ Technology Poses Solution

Posted on January 8, 2016 by MissionIR

Hoverboards were supposed to be the latest technological innovation to take the world by storm. With the Christmas shopping season fast approaching and stores struggling to keep the self-balancing motor scooters on the shelves, it appeared that these futuristic transportation … Continue reading →

Posted in Oakridge Global Energy Solutions Inc. OGES | Leave a comment

Oakridge Global Energy Solutions, Inc. (OGES) Rolls-out New Corporate Branding, Communications to Complement Full-Scale Production

Posted on January 7, 2016 by MissionIR

Oakridge Global Energy Solutions, Inc. (OTCQB: OGES) today unveiled its new corporate image, branding and media communications tools aligned with the company’s recent advancement to full production of its lithium-ion batteries and energy storage products. As part of this rebranding, … Continue reading →

Posted in Oakridge Global Energy Solutions Inc. OGES | Leave a comment